MSU
XLRN

Mizuho Securities USA’s Acceleron Pharma XLRN Stock Holding History

Mizuho Securities USA’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-28,000
Closed -$4.82M – 294
2021
Q3 		$4.82M Buy
+28,000
New +$3.66M 0.49% 48

Mizuho Securities USA's XLRN Position: Q4 2021 in Review

Mizuho Securities USA sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 28,000 shares — an estimated $4.82M sold.

Mizuho Securities USA first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $4.82M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Mizuho Securities USA reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Mizuho Securities USA sold 28,000 Acceleron Pharma shares in Q4 2021, an estimated $4.82M.
  • Mizuho Securities USA first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Mizuho Securities USA's Acceleron Pharma position peaked at $4.82M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Mizuho Securities USA's 13F filing for Q4 2021, filed 28 Jan 2022.